PJ
Pekka Juhani Kankaanpaa
About Pekka Juhani Kankaanpaa
Data last updated:
Pekka Juhani Kankaanpaa is a Director at Finorion Pharma India Private Limited (since 2025). The company operates in Pharma. Finorion Pharma India Private Limited reported revenue of ₹38.28 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Finorion Pharma India Private Limited U74120MH2011PTC225361 | Director | 24 Apr 2025 | 2011 | ₹38.28 Cr (FY 2025) | Active |
Board colleagues of Pekka Juhani Kankaanpaa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Johanna Linnea Pakkanen | 07320123 | Finorion Pharma India Private Limited | Director |
| Mikko Tapani Kemppainen | 11046428 | Finorion Pharma India Private Limited | Director |
| Olli Heikki Huotari | 05119036 | Finorion Pharma India Private Limited | Director |
| Rene Kristian Lindell | 10717452 | Finorion Pharma India Private Limited | Director |
| Samrudhi Mangesh Utturkar | 08162610 | Finorion Pharma India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pekka Juhani Kankaanpaa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pekka Juhani Kankaanpaa
Pekka Juhani Kankaanpaa currently holds 1 directorship: Finorion Pharma India Private Limited (Director, since 24 Apr 2025, revenue ₹38.28 Cr (FY 2025)).
Pekka Juhani Kankaanpaa was first appointed on 24 Apr 2025 as Director at Finorion Pharma India Private Limited.
The current boards of Pekka Juhani Kankaanpaa's companies include Johanna Linnea Pakkanen (Finorion Pharma India Private Limited), Mikko Tapani Kemppainen (Finorion Pharma India Private Limited), Olli Heikki Huotari (Finorion Pharma India Private Limited), Rene Kristian Lindell (Finorion Pharma India Private Limited), Samrudhi Mangesh Utturkar (Finorion Pharma India Private Limited).